0

    524400

    ISHITADR

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    ISHITA DRUGS & INDUSTRIES LTD. Share Price Today

    Investment Returns

    Over 1 Month 6.41% Over 3 Months -1.54% Over 6 Months 10.01% Over 1 Year -1.00%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    ISHITA DRUGS & INDUSTRIES LTD. fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 23.00
    • P/E Ratio (TTM) 29.92
    • Beta 0.57
    • Book Value / share 38.69
    • Return on equity 8.40%
    • EPS (TTM) 2.60
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 0.18
    info icon alternate text

    ISHITA DRUGS & INDUSTRIES LTD. Financials

    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 3.06
    Operating Expense 3.00
    Net Profit 0.18
    Net Profit Margin (%) 5.88
    Earnings Per Share (EPS) 0.59
    EBITDA 0.32
    Effective Tax Rate (%) 35.71
    Particulars DEC 2025 (Values in Cr)
    Revenue 3.14
    Operating Expense 3.05
    Net Profit 0.16
    Net Profit Margin (%) 5.09
    Earnings Per Share (EPS) 0.52
    EBITDA 0.24
    Effective Tax Rate (%) 21.05
    Particulars SEP 2025 (Values in Cr)
    Revenue 3.07
    Operating Expense 2.91
    Net Profit 0.14
    Net Profit Margin (%) 4.56
    Earnings Per Share (EPS) 0.48
    EBITDA 0.25
    Effective Tax Rate (%) 36.36
    Particulars JUN 2025 (Values in Cr)
    Revenue 5.40
    Operating Expense 5.10
    Net Profit 0.30
    Net Profit Margin (%) 5.55
    Earnings Per Share (EPS) 1.01
    EBITDA 0.44
    Effective Tax Rate (%) 23.07
    Particulars MAR 2025 (Values in Cr)
    Revenue 4.56
    Operating Expense 4.34
    Net Profit 0.29
    Net Profit Margin (%) 6.35
    Earnings Per Share (EPS) 0.96
    EBITDA 0.44
    Effective Tax Rate (%) 23.68
    Particulars MAR 2026 (Values in Cr)
    Revenue 14.66
    Operating Expense 14.05
    Net Profit 0.78
    Net Profit Margin (%) 5.32
    Earnings Per Share (EPS) 2.60
    EBITDA 1.24
    Effective Tax Rate (%) 27.77
    Particulars MAR 2025 (Values in Cr)
    Revenue 15.00
    Operating Expense 14.18
    Net Profit 0.87
    Net Profit Margin (%) 5.80
    Earnings Per Share (EPS) 2.90
    EBITDA 1.34
    Effective Tax Rate (%) 25.00
    Particulars MAR 2024 (Values in Cr)
    Revenue 15.19
    Operating Expense 14.48
    Net Profit 0.75
    Net Profit Margin (%) 4.93
    Earnings Per Share (EPS) 2.50
    EBITDA 1.19
    Effective Tax Rate (%) 24.24
    Particulars MAR 2023 (Values in Cr)
    Revenue 12.07
    Operating Expense 11.49
    Net Profit 0.58
    Net Profit Margin (%) 4.80
    Earnings Per Share (EPS) 1.93
    EBITDA 0.96
    Effective Tax Rate (%) 25.64
    Particulars MAR 2022 (Values in Cr)
    Revenue 14.09
    Operating Expense 13.15
    Net Profit 0.81
    Net Profit Margin (%) 5.74
    Earnings Per Share (EPS) 2.69
    EBITDA 1.19
    Effective Tax Rate (%) 23.07
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 36.08
    ROE % 8.40
    ROCE % 10.00
    Total Debt to Total Equity 0.19
    EBITDA Margin 8.87
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 33.18
    ROE % 7.86
    ROCE % 10.77
    Total Debt to Total Equity 0.05
    EBITDA Margin 7.83
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 30.68
    ROE % 6.53
    ROCE % 8.86
    Total Debt to Total Equity 0.05
    EBITDA Margin 7.95
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 28.75
    ROE % 9.76
    ROCE % 12.90
    Total Debt to Total Equity 0.00
    EBITDA Margin 8.45
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 26.05
    ROE % 11.25
    ROCE % 14.32
    Total Debt to Total Equity 0.02
    EBITDA Margin 8.82
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 4.83
    Total Assets 16.29
    Total Liabilities 16.29
    Total Equity 10.78
    Share Outstanding 0
    Price to Book Ratio 2.18
    Return on Assets (%) 5.32
    Return on Capital (%) 5.91
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 4.80
    Total Assets 10.80
    Total Liabilities 10.80
    Total Equity 9.92
    Share Outstanding 0
    Price to Book Ratio 1.98
    Return on Assets (%) 6.92
    Return on Capital (%) 7.54
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 3.42
    Total Assets 11.40
    Total Liabilities 11.40
    Total Equity 9.17
    Share Outstanding 0
    Price to Book Ratio 1.61
    Return on Assets (%) 5.06
    Return on Capital (%) 5.7
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 4.68
    Total Assets 11.25
    Total Liabilities 11.25
    Total Equity 8.59
    Share Outstanding 0
    Price to Book Ratio 1.44
    Return on Assets (%) 7.15
    Return on Capital (%) 9.36
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 2.53
    Total Assets 9.26
    Total Liabilities 9.26
    Total Equity 7.79
    Share Outstanding 0
    Price to Book Ratio 1.15
    Return on Assets (%) 8.95
    Return on Capital (%) 10.65
    Particulars MAR 2025 (Values in Cr)
    Net Income 1.15
    Cash from Operations -3.63
    Cash from Investing -0.66
    Cash from Financing 4.32
    Net change in Cash 0.02
    Free Cash Flow -3.45
    Particulars MAR 2024 (Values in Cr)
    Net Income 0.98
    Cash from Operations 2.12
    Cash from Investing 0.13
    Cash from Financing -0.86
    Net change in Cash 1.38
    Free Cash Flow 2.14
    Particulars MAR 2023 (Values in Cr)
    Net Income 0.77
    Cash from Operations -2.89
    Cash from Investing 0.59
    Cash from Financing 1.04
    Net change in Cash -1.25
    Free Cash Flow -2.76
    Particulars MAR 2022 (Values in Cr)
    Net Income 1.04
    Cash from Operations 3.07
    Cash from Investing -0.93
    Cash from Financing 0.00
    Net change in Cash 2.14
    Free Cash Flow 3.09
    Particulars MAR 2021 (Values in Cr)
    Net Income 1.05
    Cash from Operations -0.67
    Cash from Investing 2.45
    Cash from Financing -0.23
    Net change in Cash 1.53
    Free Cash Flow -0.66
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 42.42 17.60 2.05 325.08 23.12 43.00
    BLISS GVS PHARMA LTD 488.95 39.37 4.35 5194.80 118.35 552.90
    CIPLA LTD. 1450.00 32.73 3.40 117137.57 1165.55 1672.20
    FERMENTA BIOTECH LTD. 546.75 25.57 3.95 1609.14 256.40 551.25
    GLAXOSMITHKLINE PHARMA LT 2647.45 42.60 19.77 44849.40 2088.00 2935.85
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 42.42 29.66 5.46 325.08 23.12 43.00
    AMRUTANJAN HEALTH CARE LTD. 517.35 23.19 4.03 1495.69 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8173.90 106.82 23.41 20434.75 7630.00 9850.00
    BLISS GVS PHARMA LTD 488.95 52.92 4.49 5194.80 118.35 552.90

    ISHITA DRUGS & INDUSTRIES LTD. shareholding pattern

    Holding
    49.96%
    50.03%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    ISHITA DRUGS & INDUSTRIES LTD. Technicals Summary

    77.00 -1.00 redarrow
    red-green-graph indicator
    2 Bearish
    14 Bullish
    • 5 Days 76.20
    • 26 Days 74.60
    • 10 Days 75.10
    • 50 Days 75.10
    • 12 Days 74.90
    • 100 Days 75.40
    • 20 Days 74.50
    • 200 Days 75.70
    76.28 PIVOT
    First Support 74.75 First Resistance 79.30 Second Support 71.73 Second Resistance 80.83 Third Support 70.20 Third Resistance 83.85
    RSI 60.39 ADX 45.71 MACD 0.33 Williams % R -0.21 Commodity Channel Index (CCI) 122.52
    Date 2026-08-04 Week 1319.00 Same Day 2128.00 Month 492.00
    1 Year 0.57 3 Year 0.44
    Over 1 Month
    6.41% down
    Over 1 Year
    -1.00% down
    Over 3 Months
    -1.54% down
    Over 3 Years
    2.48% down
    Over 6 Months
    10.01% down
    Over 5 Years
    11.61% down

    ISHITA DRUGS & INDUSTRIES LTD. Corporate Actions

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Ishita Drugs & Industries Ltd?

    Answer Field

    Ishita Drugs & Industries Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 77.00 as on Aug 06 2026 09:09 AM.

    What is the Market Cap of Ishita Drugs & Industries Ltd Share?

    Answer Field

    The market cap of Ishita Drugs & Industries Ltd for NSE ₹ 0.00 & for BSE ₹ 23.00 as on Aug 06 2026 09:09 AM.

    What is the 52 Week High and Low of Ishita Drugs & Industries Ltd?

    Answer Field

    The 52 Week High and Low of Ishita Drugs & Industries Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 90.85 and ₹ 66.00.

    What is 1 year return for Ishita Drugs & Industries Ltd?

    Answer Field

    The 1 year returns on the stock has been -1.00%.

    What is the P/E Ratio of Ishita Drugs & Industries Ltd Share?

    Answer Field

    As on Aug 06 2026 09:09 AM the price-to-earnings (PE) ratio for Ishita Drugs & Industries Ltd share is 29.92.

    What is the PB ratio of Ishita Drugs & Industries Ltd Share?

    Answer Field

    As on Aug 06 2026 09:09 AM, the price-to-book (PB) ratio for Ishita Drugs & Industries Ltd share is 38.69.

    How to Buy Ishita Drugs & Industries Ltd Share?

    Answer Field

    You can trade in Ishita Drugs & Industries Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Ishita Drugs & Industries Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Ishita Drugs & Industries Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Ishita Drugs & Industries Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |